Skip to content
Annika Bansal – Lifestyle
Author:
AiCuris Anti-infective Cures AG
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
April 16, 2026
Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1
March 4, 2026